Table 3 of Polisetti, Mol Vis 2010; 16:1227-1240.


Table 3. Differential gene expression between LEC and MC-L in growth factors and cytokine related genes.



Gene
LEC
versus
MC-L
LEC
versus
MSCBM
MC-L
versus
MSCBM
amphiregulin (schwannoma-derived growth factor) (AREG) 167.6 (Down) 131.25 (down) 3.74 (down)
transforming growth factor, alpha (TGFA) 57.21 (down) 28.49 (down)  
fibroblast growth factor binding protein 1 (FGFBP1) 38.75 (down) 23.011 (down)  
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (FLT1) 31.0 (up)   96.42 (down)
Platelet derived growth factor receptor alpha (PDGFRA) 26.10 (up) 33.93 (up)  
platelet-derived growth factor receptor, beta polypeptide (PDGFRB) 20.52 (up) 21.90 (up)  
insulin-like growth factor binding protein 5 (IGFBP5) 17.65 (up) 14.81 (up)  
growth factor receptor-bound protein 14 (GRB14) 17.23 (down) 5.82 (down) 2.95 (down)
fibroblast growth factor 2 (basic) (FGF2) 13.78 (up)    
fibroblast growth factor 11 (FGF11) 12.83 (down)    
keratinocyte growth factor-like protein 1 (KGFLP1) 10.9 (up)   9.85 (up)
fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) (FGFR1) 10.50 (up) 8.96 (up)  
insulin-like growth factor 2 (somatomedin A) (IGF2) 9.9 (up) 6.2 (up)  
connective tissue growth factor (CTGF) 9.77 (up) 15.45 (up) 2.3 (up)
pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1) (PTN) 8.54 (up) 9.9 (up)  
insulin-like growth factor 2 mRNA binding protein 1 (IGF2BP1) 8.10 (up)    
fibroblast growth factor 1 (acidic) (FGF1) 8.03 (up) 5.41 (up) 7.41 (down)
Insulin-like growth factor binding protein 4 (IGFBP4) 7.65 (up) 14.2 (up) 2.96 (up)
fibroblast growth factor 7 (keratinocyte growth factor) (FGF7) 7.51 (up) 15 (up) 4.51 (up)
platelet derived growth factor D (PDGFD) 5.97 (up) 12.7 (up)  
fibroblast growth factor binding protein 3 (FGFBP3) 5.68 (up) 4.4 (up)  
insulin-like growth factor binding protein 5 (IGFBP5) 5.61 (up) 5.4 (up) 2.95 (down)
fibroblast growth factor receptor 2 (fgfr2) 4.50 (down)   4.89 (up)
Hepatocyte growth factor precursor (Scatter factor) (SF) (Hepatopoeitin-A) 4.05 (up) 10.06 (up)  
transforming growth factor beta 1 induced transcript 1 (TGFB1I1), transcript variant 2 3.94 (up) 2.97 (up)  
nerve growth factor, beta polypeptide (NGFB) 3.83 (up)   2.6 (down)
chemokine (C-X-C motif) ligand 2 (CXCL2) 79.06 (down) 4.5 (down)  
chemokine (C-X-C motif) ligand 3 (CXCL3) 26.25 (down) 16.0 (down) 3.88 (up)
chemokine (C-X-C motif) ligand 1 (CXCL1) 65.87 (down) 64.9 (down)  
chemokine (C-X-C motif) ligand 11 (CXCL11) 58.344 (down) 14.42 (down)  
chemokine (C-X-C motif) ligand 10 (CXCL10) 7.71 (down) 6.97 (down)  
chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) (CXCL12) 34.26 (up) 82.68 (up)  
chemokine (C-C motif) ligand 26 (CCL26) 11.4 (up) 2.49 (up)  
chemokine (C-C motif) ligand 2 (CCL2) 23.43 (up)   3.48 (down)
chemokine (C-C motif) ligand 13 (CCL13) 12.42 (up)   2.34 (up)
interleukin 1, alpha (IL1A) 78.72 (down) 63.61 (down)  
interleukin 1, beta (IL1B) 48.57 (down) 28.89 (down)  
interleukin 1 receptor, type II (IL1R2) 12.17 (down) 21.03 (down) 3.92 (up)
interleukin 1 receptor antagonist (IL1RN) 20.06 (down) 15.10 (down)  
interleukin 20 receptor, alpha (IL20RA) 210.69 (down)    
interleukin 18 (interferon-gamma-inducing factor) (IL18) 78.26 (down) 56.72 (down)  
interleukin 23, alpha subunit p19 (IL23A) 28.40 (down) 29.29 (down)  
interleukin 11 receptor, alpha (IL11RA) 15.58 (up)    
neurotrophin 5 (NTF5) 14.96 (down) 11.64 (up)  
neurotrophin 3 (NTF3) 16.40 (up) 7.50 (up) 7.48 (down)
nerve growth factor, beta polypeptide (NGFB) 3.8 (up)    
Glial cell line-derived neurotrophic factor precursor (Astrocyte- derived trophic factor 1) 4.24 (up) 6.56 (up)  
GDNF family receptor alpha 1 (GFRA1) 6.5 (up) 6.28 (up)  
brain-derived neurotrophic factor (BDNF) 9.15 (up) 3.69 (up) 8.68 (down)